RBC Capital Maintains Outperform on Eli Lilly, Raises Price Target to $1600

Benzinga · 2d ago
RBC Capital analyst Trung Huynh maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $1500 to $1600.